- 4Q EARNINGS: Is 2015 Lilly's turning point?
- 1Q EARNINGS: Lilly sales sink as growth floats to 2015
- 3Q EARNINGS: Lilly looks to future as revenue falls
- 3Q EARNINGS: Tecfidera sales soar, but PML death hits Biogen
COMMENT Other Informa Comment
- PROFILE: Tomas Salmonson, chair of the EMA's CHMP, on European collaboration, being a teenage lifeguard, and Persian rugs
- Profile: Dr Reddy's CEO on mass exits, listening to parents & architecture
JOB OF THE WEEK Promote your job vacancy